Pfizer Submits Covid-19 Pill for FDA Authorization

Testing found Pfizer’s pill to be 89% effective at reducing the risk of hospitalization and death from Covid-19 when taken soon after diagnosis.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept Learn more…